Archives
Long-term COVID-19 containment will be shaped by strength, duration of immunity
23 Sep, 2020 | 14:51h | UTCOriginal Article: Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years – Science
Perspective: Which Sweden do you want to believe in?
23 Sep, 2020 | 14:47h | UTCWhich Sweden Do You Want to Believe In? – McGill
The first eight months of Sweden’s COVID‐19 strategy and the key actions and actors that were involved
23 Sep, 2020 | 14:48h | UTC
COVID-19 clinical trials: Learning from exceptions in the research chaos
23 Sep, 2020 | 14:50h | UTCCOVID-19 clinical trials: learning from exceptions in the research chaos – Nature
Commentary on Twitter
Our analysis on #COVID clinical trials on Nature Medicine. Only big randomised trials can answer rapidly & reliably. Megatrials need support from regulators, funders, health services, docs. Pre-existing trial networks helpful. Collaboration key to success. https://t.co/YlalAEMR9r pic.twitter.com/wElfXfXdol
— Kari Tikkinen (@KariTikkinen) September 22, 2020
Sweden spared surge of virus cases but many questions remain
23 Sep, 2020 | 14:45h | UTCSweden spared surge of virus cases but many questions remain – Associated Press
NICE Guideline: Low back pain and sciatica in over 16s
23 Sep, 2020 | 14:41h | UTC
Tracking COVID-19 with wastewater
23 Sep, 2020 | 14:43h | UTCTracking COVID-19 with wastewater – Nature Biotechnology
USPSTF draft statement: Insufficient evidence to screen for Vitamin D deficiency in asymptomatic adults
23 Sep, 2020 | 14:36h | UTC
NICE Guideline: Antimicrobial prescribing for insect bites and stings
23 Sep, 2020 | 14:40h | UTC
Cardiac arrhythmias in critically ill patients with COVID-19: A brief review
22 Sep, 2020 | 09:59h | UTC
Catheter-associated urinary tract infections in adults: diagnosis, treatment, and prevention
23 Sep, 2020 | 14:35h | UTCCatheter-Associated Urinary Tract Infections in Adults: Diagnosis, Treatment, and Prevention – Journal of Hospital Medicine (free for a limited period)
What can we expect from first-generation COVID-19 vaccines?
22 Sep, 2020 | 10:02h | UTCWhat can we expect from first-generation COVID-19 vaccines? – The Lancet
Commentary on Twitter
We need to calibrate our expectations for the 1st generation of #SARSCoV2 vaccines https://t.co/QTJbyOd9xQ @TheLancet by @gmleunghku and Malik Peiris @hkumed Pe-covid normalcy is not near. pic.twitter.com/Y15TqfoRlf
— Eric Topol (@EricTopol) September 21, 2020
The core lesson of the COVID-19 heart debate
22 Sep, 2020 | 10:00h | UTCThe Core Lesson of the COVID-19 Heart Debate – The Atlantic
Commentary on Twitter
https://twitter.com/ChecchiaPaul/status/1308065655099478018
Clinical review: Emerging immunotherapies in multiple myeloma
23 Sep, 2020 | 14:33h | UTCEmerging immunotherapies in multiple myeloma – The BMJ
Commentary on Twitter
Despite advances in treatment in the past 20yrs, multiple myeloma remains an incurable disease. This review summarizes the evidence of these various immunotherapies, their mechanism of action, and data on treatments' safety and efficacy #BMJEducation https://t.co/JWeMlJ89YR
— The BMJ (@bmj_latest) September 22, 2020
Hospital COVID-19 risk lowest among intensive care staff
22 Sep, 2020 | 09:53h | UTCHospital COVID-19 risk lowest among intensive care staff – MedicalXpress
Original Study: SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study – Thorax
Commentary on Twitter
HOT OF THE PRESS@ThoraxBMJ#Covid19UK#NHS hospital staff
Asymptomatic viral carriage
2.4%Seroprevalence
▶️ Housekeeping 34.5%
▶️ Acute medicine 33.3%
▶️ General internal medicine 30.3%
▶️ Intensive care 14.8%#protectNHSstaff#protectNHSpatientshttps://t.co/iqBKl3qLYD— Prof. Nicholas Hart (@NickHartGSTT) September 12, 2020
Interesting conversation: Lockdowns, COVID mortality, & when science & politics collide (w/Dr. Eran Bendavid)
22 Sep, 2020 | 09:49h | UTCLockdowns, COVID Mortality, & When Science & Politics Collide (w/Dr. Eran Bendavid) (via @ZDoggMD)
Ensuring adequate palliative and hospice care during COVID-19 surges
22 Sep, 2020 | 09:57h | UTCEnsuring Adequate Palliative and Hospice Care During COVID-19 Surges – JAMA
Commentary on Twitter
An ethical approach to #pandemic surge planning requires providing for patients seeking symptom relief & comfort at the end of life. Not to do so undermines patient, family trust, emotional health, and core values of society https://t.co/P0LeYuZwzt @MatthewWynia @CUPallCare
— JAMA (@JAMA_current) September 22, 2020
‘Landmark moment’: 156 countries agree to Covid vaccine allocation deal
22 Sep, 2020 | 09:45h | UTC‘Landmark moment’: 156 countries agree to Covid vaccine allocation deal – The Guardian
WHO unveils global plan to fairly distribute COVID-19 vaccine, but challenges await
22 Sep, 2020 | 09:47h | UTCWHO unveils global plan to fairly distribute COVID-19 vaccine, but challenges await – Science
How bad has the pandemic been for childhood vaccinations?
22 Sep, 2020 | 09:41h | UTCHow Bad Has The Pandemic Been For Childhood Vaccinations? – NPR
Perspective: After Coronavirus Disease 2019
22 Sep, 2020 | 09:38h | UTCAfter Coronavirus Disease 2019 – Clinical Infectious Diseases
Commentary on Twitter
Great commentary on "After #COVID19" from epi/ID legend Dr. Richard Wenzel; outlines what an ideal pandemic response would look like and looks ahead to the inevitable next pandemic.
[I did have to look up "ineluctable"]@VCUHealth https://t.co/W4cOxYDjL1
— Mike Stevens (@Dr_Mike_Stevens) September 17, 2020
To find a vaccine for COVID-19, will we have to deliberately infect people?
22 Sep, 2020 | 09:40h | UTCTo find a vaccine for COVID-19, will we have to deliberately infect people? – National Geographic
Editorial: How severe COVID-19 infection is changing ARDS management
22 Sep, 2020 | 09:37h | UTCHow severe COVID-19 infection is changing ARDS management – Intensive Care Medicine
Guideline: Management of dyslipidemia for cardiovascular disease risk reduction
22 Sep, 2020 | 09:33h | UTCSummary: VA/DoD Guidelines on Dyslipidemia Recommend Against Frequent LDL Testing – NEJM Journal Watch
Commentary on Twitter
https://twitter.com/ATallantMD/status/1308199038513278978
Editorial: Two remedies for inappropriate percutaneous coronary intervention—closing the gap between evidence and practice
22 Sep, 2020 | 09:28h | UTCEditorial: Two Remedies for Inappropriate Percutaneous Coronary Intervention—Closing the Gap Between Evidence and Practice (free for a limited period)
Original Studies: Potential Association of the ISCHEMIA Trial With the Appropriate Use Criteria Ratings for Percutaneous Coronary Intervention in Stable Ischemic Heart Disease – JAMA Internal Medicine (free for a limited period) AND US False Claims Act Investigations of Unnecessary Percutaneous Coronary Interventions – JAMA Internal Medicine (free for a limited period)